- Home
- Publications
- Publication Search
- Publication Details
Title
TLR2 and TLR4 in Ischemia Reperfusion Injury
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2010, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2010-06-09
DOI
10.1155/2010/704202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways
- (2010) Jian-Wen Dong et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Over-expression of Toll-like receptors and their ligands in small-for-size graft
- (2010) Weiwei Jiang et al. HEPATOLOGY RESEARCH
- Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury
- (2010) Krisztina Rusai et al. PEDIATRIC NEPHROLOGY
- Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury
- (2009) Wang Hui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice
- (2009) Fang Hua et al. BRAIN RESEARCH
- Orphan targets for reperfusion injury
- (2009) J. Inserte et al. CARDIOVASCULAR RESEARCH
- Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody
- (2009) Fatih Arslan et al. CIRCULATION
- Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling
- (2009) S. Wang et al. Disease Models & Mechanisms
- Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia
- (2009) Peng Zhao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Resident Dendritic Cells Prevent Postischemic Acute Renal Failure by Help of Single Ig IL-1 Receptor-Related Protein
- (2009) M. Lech et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptors and Renal Disease
- (2009) Michael G. Robson NEPHRON EXPERIMENTAL NEPHROLOGY
- Toll-like receptor 2 is protective of ischemia–reperfusion-mediated small-bowel injury in a murine model
- (2009) Charles J. Aprahamian et al. Pediatric Critical Care Medicine
- Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation
- (2009) B. Kruger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders
- (2009) Masayuki Fukata et al. SEMINARS IN IMMUNOLOGY
- The Relative Effects of Warm and Cold Ischemic Injury in an Experimental Model of Nonheartbeating Donor Kidneys
- (2009) Sarah A. Hosgood et al. TRANSPLANTATION
- Mechanisms of Toll-Like Receptor 4 (TLR4)-Mediated Inflammation After Cold Ischemia/Reperfusion in the Heart
- (2009) David J. Kaczorowski et al. TRANSPLANTATION
- Activation of hepatocytes by extracellular heat shock protein 72
- (2008) Elizabeth Galloway et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets
- (2008) Fatih Arslan et al. CURRENT PHARMACEUTICAL DESIGN
- Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury
- (2008) Fang Hua et al. JOURNAL OF NEUROIMMUNOLOGY
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
- (2008) Elizabeth Murphy et al. PHYSIOLOGICAL REVIEWS
- Toll-Like Receptor-4 Coordinates the Innate Immune Response of the Kidney to Renal Ischemia/Reperfusion Injury
- (2008) Wilco P. Pulskens et al. PLoS One
- Ischemia/Reperfusion Injury in Kidney Transplantation: Mechanisms and Prevention
- (2008) M. Kosieradzki et al. TRANSPLANTATION PROCEEDINGS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started